Edwards Lifesciences | EW - Pre Tax Profit

Stock Price
86.62
Daily Change
0.72 0.84%
Monthly
5.81%
Yearly
20.94%
Q1 Forecast
77.31

Edwards Lifesciences reported $348.4M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Abbott USD 2.36B 178M Dec/2025
Artivion USD -1.27M 1.16M Sep/2024
AtriCure USD 2.36M 2.45M Dec/2025
Baxter International USD 121M 12M Sep/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Boston Scientific USD 938M 3M Sep/2025
Cooper Companies USD 254.2M 27.6M Jun/2025
Dexcom USD 300M 58.9M Sep/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Globus Medical USD 143.99M 44.18M Sep/2025
Hologic USD 229.7M 2.3M Dec/2025
ICU Medical USD 70.3M 36.62M Sep/2025
Inogen USD -6.06M 467K Sep/2024
Insulet USD 140.2M 17.4M Dec/2025
Integra LifeSciences USD -6.82M 524.13M Sep/2025
Intuitive Surgical USD 855.2M 23.1M Sep/2025
J&J USD 4.97B 2.53B Dec/2025
Masimo USD 74.9M 19.5M Sep/2025
Medtronic USD 2.1B 224M Sep/2025
Merit Medical Systems USD 73.18M 29.8M Sep/2025
Stryker USD 1.03B 13M Sep/2025
Tandem Diabetes Care USD -25.14M 32.58M Sep/2025
Teleflex USD -438.58M 573.82M Sep/2025
Zimmer Biomet Holdings USD 418.7M 194.1M Sep/2025